(Q33962863)

30 July 2017

1 reference

title

Defects of TGF-beta receptor signaling in mammary cell tumorigenesis (English)

1 reference

30 July 2017

Brattain MG

1

1 reference

30 July 2017

Ko Y

2

1 reference

30 July 2017

Banerji SS

3

1 reference

30 July 2017

Wu G

4

1 reference

30 July 2017

Willson JK

5

1 reference

30 July 2017

publication date

1 October 1996

1 reference

Journal of Mammary Gland Biology and Neoplasia

30 July 2017

published in

1 reference

30 July 2017

volume

1

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

365-372

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02017392

30 July 2017

exact match

0 references

cites work

Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02017392

1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells

21 January 2018

1 reference

12 December 2020

Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells

1 reference

12 December 2020

Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3

1 reference

12 December 2020

TGF-beta-receptor-mediated signaling

1 reference

12 December 2020

The transforming growth factor beta receptors types I, II, and III form hetero-oligomeric complexes in the presence of ligand

1 reference

12 December 2020

Homomeric interactions between type II transforming growth factor-beta receptors.

1 reference

12 December 2020

20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.

1 reference

12 December 2020

The retinoblastoma protein and cell cycle control

1 reference

12 December 2020

Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12

1 reference

12 December 2020

Transforming growth factor beta 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice

1 reference

12 December 2020

Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells

1 reference

12 December 2020

Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.

1 reference

12 December 2020

Mammary tumor suppression by transforming growth factor beta 1 transgene expression

1 reference

12 December 2020

Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase

1 reference

12 December 2020

Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism

1 reference

12 December 2020

Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells

1 reference

12 December 2020

Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta

1 reference

12 December 2020

Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells

1 reference

12 December 2020

The TGF-beta family and its composite receptors

1 reference

12 December 2020

Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue.

1 reference

12 December 2020

Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells

1 reference

12 December 2020

Inhibitors of mammalian G1 cyclin-dependent kinases

1 reference

12 December 2020

A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene

1 reference

12 December 2020

Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1.

1 reference

12 December 2020

Overexpression of human cyclin D1 reduces the transforming growth factor beta (TGF-beta) type II receptor and growth inhibition by TGF-beta 1 in an immortalized human esophageal epithelial cell line

1 reference

12 December 2020

Effects of transforming growth factor beta on growth of human mammary epithelial cells in culture

1 reference

12 December 2020

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

1 reference

12 December 2020

Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line

1 reference

12 December 2020

Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-

1 reference

12 December 2020

TGF beta signals through a heteromeric protein kinase receptor complex

1 reference

12 December 2020

Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro

1 reference

12 December 2020

A transforming growth factor beta type I receptor that signals to activate gene expression

1 reference

12 December 2020

TGF beta induction of extracellular matrix associated proteins in normal and transformed human mammary epithelial cells in culture is independent of growth effects

1 reference

12 December 2020

Loss of receptors for transforming growth factor beta in human T-cell malignancies.

1 reference

12 December 2020

Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta

1 reference

12 December 2020

TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector

1 reference

12 December 2020

Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor

1 reference

12 December 2020

Regulation of the levels of three transforming growth factor beta mRNAs by estrogen and their effects on the proliferation of human breast cancer cells

1 reference

12 December 2020

Resistance to transforming growth factor beta and activin due to reduced receptor expression in human breast tumor cell lines.

1 reference

12 December 2020

Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties.

1 reference

12 December 2020

Mechanism of activation of the TGF-beta receptor

1 reference

12 December 2020

Effects of TGF-beta 1 (transforming growth factor-beta 1) on the cell cycle regulation of human breast adenocarcinoma (MCF-7) cells.

1 reference

12 December 2020

Betaglycan presents ligand to the TGF beta signaling receptor.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02017392

1 reference

30 July 2017

1 reference